VanEck Pharmaceutical ETF (NASDAQ:PPH) to Issue Quarterly Dividend of $0.52

VanEck Pharmaceutical ETF (NASDAQ:PPH) declared a quarterly dividend on Monday, March 31st, NASDAQ Dividends reports. Stockholders of record on Tuesday, April 1st will be paid a dividend of 0.5245 per share on Friday, April 4th. This represents a $2.10 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date of this dividend is Tuesday, April 1st. This is a 70.6% increase from VanEck Pharmaceutical ETF’s previous quarterly dividend of $0.31.

VanEck Pharmaceutical ETF Trading Down 2.6 %

NASDAQ:PPH traded down $2.40 during trading hours on Tuesday, reaching $88.73. 96,738 shares of the company were exchanged, compared to its average volume of 188,975. The firm has a market cap of $553.68 million, a PE ratio of 27.82 and a beta of 0.72. VanEck Pharmaceutical ETF has a twelve month low of $84.48 and a twelve month high of $99.51. The stock’s 50-day moving average is $90.90 and its 200-day moving average is $90.60.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.